GLP-1 Agonists Explored for Kidney Protection in Non-Diabetic Conditions | Retatrutide News

The study examines GLP-1 receptor agonists for kidney protection in non-diabetic conditions. This research could inform future applications of Retatrutide.
Clinical Trials · October 20, 2026